| Jay Prochnau, MD | |
|
1500 Salem St, Lafayette, IN 47904-2164 | |
| (765) 448-8000 | |
| (765) 448-8564 |
| Full Name | Jay Prochnau |
|---|---|
| Gender | Male |
| Speciality | Allergy/immunology |
| Experience | 25 Years |
| Location | 1500 Salem St, Lafayette, Indiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1366411878 | NPI | - | NPPES |
| 000000372081 | Other | IN | ANTHEM PROVIDER NUMBER |
| 200536580 | Medicaid | IN | |
| 9333888 | Other | IN | PHCS PID NUMBER |
| 11438471 | Other | IN | CAQH NUMBER |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207KA0200X | Allergy & Immunology - Allergy | 01060643A (Indiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Indiana University Health Arnett Hospital | Lafayette, IN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Arnett Clinic Llc | 0749184380 | 380 |
News Archive
RXi Pharmaceuticals Corporation (Nasdaq: RXII), a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference (RNAi), announced today that Tod Woolf, Ph.D., President and CEO, along with members of RXi's management team, will ring the Nasdaq closing bell tomorrow, Tuesday, Oct 6, 2009 at the Nasdaq Marketsite in New York City's Times Square.
What keeps most infectious disease researchers up at night aren't infamous viruses like Ebola. Instead, influenza, commonly known as the flu, continues to be a clear and present danger to humanity.
Cancer Research UK scientists have shown that an enzyme can re-expand the insides of blood vessels allowing more drugs and large antibody molecules to reach pancreatic tumours, according to research published in GUT today.
DiaSorin and Tecan Group have announced that they have agreed to collaborate in a development under which DiaSorin will make use of Tecan's Fluent Laboratory Automation Solution as its nucleic acid extraction platform.
Katherine A. High, M.D., of The Children's Hospital of Philadelphia was honored for her trailblazing scientific and clinical research in the bleeding disorder hemophilia when she received the 2013 E. Donnall Thomas Prize from the American Society of Hematology at its annual meeting on Dec. 9 in New Orleans.
› Verified 9 days ago
| Entity Name | Arnett Clinic Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1164490843 PECOS PAC ID: 0749184380 Enrollment ID: O20031125000119 |
News Archive
RXi Pharmaceuticals Corporation (Nasdaq: RXII), a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference (RNAi), announced today that Tod Woolf, Ph.D., President and CEO, along with members of RXi's management team, will ring the Nasdaq closing bell tomorrow, Tuesday, Oct 6, 2009 at the Nasdaq Marketsite in New York City's Times Square.
What keeps most infectious disease researchers up at night aren't infamous viruses like Ebola. Instead, influenza, commonly known as the flu, continues to be a clear and present danger to humanity.
Cancer Research UK scientists have shown that an enzyme can re-expand the insides of blood vessels allowing more drugs and large antibody molecules to reach pancreatic tumours, according to research published in GUT today.
DiaSorin and Tecan Group have announced that they have agreed to collaborate in a development under which DiaSorin will make use of Tecan's Fluent Laboratory Automation Solution as its nucleic acid extraction platform.
Katherine A. High, M.D., of The Children's Hospital of Philadelphia was honored for her trailblazing scientific and clinical research in the bleeding disorder hemophilia when she received the 2013 E. Donnall Thomas Prize from the American Society of Hematology at its annual meeting on Dec. 9 in New Orleans.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jay Prochnau, MD 1200 W White River Blvd, Muncie, IN 47303-4988 Ph: (877) 668-5621 | Jay Prochnau, MD 1500 Salem St, Lafayette, IN 47904-2164 Ph: (765) 448-8000 |
News Archive
RXi Pharmaceuticals Corporation (Nasdaq: RXII), a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference (RNAi), announced today that Tod Woolf, Ph.D., President and CEO, along with members of RXi's management team, will ring the Nasdaq closing bell tomorrow, Tuesday, Oct 6, 2009 at the Nasdaq Marketsite in New York City's Times Square.
What keeps most infectious disease researchers up at night aren't infamous viruses like Ebola. Instead, influenza, commonly known as the flu, continues to be a clear and present danger to humanity.
Cancer Research UK scientists have shown that an enzyme can re-expand the insides of blood vessels allowing more drugs and large antibody molecules to reach pancreatic tumours, according to research published in GUT today.
DiaSorin and Tecan Group have announced that they have agreed to collaborate in a development under which DiaSorin will make use of Tecan's Fluent Laboratory Automation Solution as its nucleic acid extraction platform.
Katherine A. High, M.D., of The Children's Hospital of Philadelphia was honored for her trailblazing scientific and clinical research in the bleeding disorder hemophilia when she received the 2013 E. Donnall Thomas Prize from the American Society of Hematology at its annual meeting on Dec. 9 in New Orleans.
› Verified 9 days ago
Ketan K Sheth, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 1345 Unity Pl, Suite 145a, Lafayette, IN 47905 Phone: 765-446-5040 Fax: 765-446-5041 | |
Dr. Namrata Singhal, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 1500 Salem St, Lafayette, IN 47904 Phone: 765-448-8000 |